Retatrutide, by Soma Pharmaceuticals , represents a promising development in metabolic management . This unique medication combines GLP-1 receptor agonist function with gut-derived receptor activation , demonstrating substantial efficacy in clinical studies for weight reduction . Experts believe the drug may offer a new pathway for people strugglin